Literature DB >> 32020474

Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery.

Chih-Ying Huang1,2, Cheng-Chia Lee2,3,4, Huai-Che Yang2,3, Chung-Jung Lin2,5, Hsiu-Mei Wu2,5, Wen-Yuh Chung2,3, Cheng-Ying Shiau2,6, Wan-Yuo Guo2,5, David Hung-Chi Pan3,7, Syu-Jyun Peng8.   

Abstract

PURPOSE: Gamma Knife radiosurgery (GKRS) is a non-invasive procedure for the treatment of brain metastases. This study sought to determine whether radiomic features of brain metastases derived from pre-GKRS magnetic resonance imaging (MRI) could be used in conjunction with clinical variables to predict the effectiveness of GKRS in achieving local tumor control.
METHODS: We retrospectively analyzed 161 patients with non-small cell lung cancer (576 brain metastases) who underwent GKRS for brain metastases. The database included clinical data and pre-GKRS MRI. Brain metastases were demarcated by experienced neurosurgeons, and radiomic features of each brain metastasis were extracted. Consensus clustering was used for feature selection. Cox proportional hazards models and cause-specific proportional hazards models were used to correlate clinical variables and radiomic features with local control of brain metastases after GKRS.
RESULTS: Multivariate Cox proportional hazards model revealed that higher zone percentage (hazard ratio, HR 0.712; P = .022) was independently associated with superior local tumor control. Similarly, multivariate cause-specific proportional hazards model revealed that higher zone percentage (HR 0.699; P = .014) was independently associated with superior local tumor control.
CONCLUSIONS: The zone percentage of brain metastases, a radiomic feature derived from pre-GKRS contrast-enhanced T1-weighted MRIs, was found to be an independent prognostic factor of local tumor control following GKRS in patients with non-small cell lung cancer and brain metastases. Radiomic features indicate the biological basis and characteristics of tumors and could potentially be used as surrogate biomarkers for predicting tumor prognosis following GKRS.

Entities:  

Keywords:  Brain metastasis; Gamma knife radiosurgery; Magnetic resonance imaging; Prognosis; Radiomics

Mesh:

Year:  2020        PMID: 32020474     DOI: 10.1007/s11060-019-03343-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  43 in total

1.  Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases.

Authors:  Daniel Gorovets; Diandra Ayala-Peacock; David J Tybor; Paul Rava; Daniel Ebner; Deus Cielo; Georg Norén; David E Wazer; Michael Chan; Jaroslaw T Hepel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-10-01       Impact factor: 7.038

2.  Gamma knife radiosurgery for brain metastases: prognostic factors for survival and local control.

Authors:  D G Kim; H T Chung; H S Gwak; S H Paek; H W Jung; D H Han
Journal:  J Neurosurg       Date:  2000-12       Impact factor: 5.115

3.  A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy.

Authors:  Diandra N Ayala-Peacock; Ann M Peiffer; John T Lucas; Scott Isom; J Griff Kuremsky; James J Urbanic; J Daniel Bourland; Adrian W Laxton; Stephen B Tatter; Edward G Shaw; Michael D Chan
Journal:  Neuro Oncol       Date:  2014-02-20       Impact factor: 12.300

4.  Hypoxia and radiation therapy: past history, ongoing research, and future promise.

Authors:  Sara Rockwell; Iwona T Dobrucki; Eugene Y Kim; S Tucker Marrison; Van Thuc Vu
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

5.  Gamma knife surgery in the management of brain metastases from lung carcinoma: a retrospective analysis of survival, local tumor control, and freedom from new brain metastasis.

Authors:  Ajay Jawahar; Ronnie E Matthew; Alireza Minagar; Deepti Shukla; John H Zhang; Brian K Willis; Federico Ampil; Anil Nanda
Journal:  J Neurosurg       Date:  2004-05       Impact factor: 5.115

6.  Tumor volume as a predictor of survival and local control in patients with brain metastases treated with Gamma Knife surgery.

Authors:  Andrew M Baschnagel; Kurt D Meyer; Peter Y Chen; Daniel J Krauss; Rick E Olson; Daniel R Pieper; Ann H Maitz; Hong Ye; Inga Siiner Grills
Journal:  J Neurosurg       Date:  2013-08-23       Impact factor: 5.115

7.  Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.

Authors:  Nathaniel M Braman; Maryam Etesami; Prateek Prasanna; Christina Dubchuk; Hannah Gilmore; Pallavi Tiwari; Donna Plecha; Anant Madabhushi
Journal:  Breast Cancer Res       Date:  2017-05-18       Impact factor: 6.466

8.  EGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases.

Authors:  Hsin-Lun Lee; Tao-Sang Chung; Lai-Lei Ting; Jo-Ting Tsai; Shang-Wen Chen; Jeng-Fong Chiou; Henry Wing-Cheung Leung; H Eugene Liu
Journal:  Radiat Oncol       Date:  2012-10-30       Impact factor: 3.481

9.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.

Authors:  Hugo J W L Aerts; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Chintan Parmar; Patrick Grossmann; Sara Carvalho; Sara Cavalho; Johan Bussink; René Monshouwer; Benjamin Haibe-Kains; Derek Rietveld; Frank Hoebers; Michelle M Rietbergen; C René Leemans; Andre Dekker; John Quackenbush; Robert J Gillies; Philippe Lambin
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

10.  Radiomic feature clusters and prognostic signatures specific for Lung and Head & Neck cancer.

Authors:  Chintan Parmar; Ralph T H Leijenaar; Patrick Grossmann; Emmanuel Rios Velazquez; Johan Bussink; Derek Rietveld; Michelle M Rietbergen; Benjamin Haibe-Kains; Philippe Lambin; Hugo J W L Aerts
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

View more
  12 in total

1.  Editorial: advances in neuro-oncology and clinical treatment-from ASNO 2019.

Authors:  Pin-Yuan Chen; Kuo-Chen Wei
Journal:  J Neurooncol       Date:  2020-02-04       Impact factor: 4.130

2.  The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study.

Authors:  Yixin Wang; Jinwei Lang; Joey Zhaoyu Zuo; Yaqin Dong; Zongtao Hu; Xiuli Xu; Yongkang Zhang; Qinjie Wang; Lizhuang Yang; Stephen T C Wong; Hongzhi Wang; Hai Li
Journal:  Eur Radiol       Date:  2022-06-09       Impact factor: 5.315

3.  Predicting the Local Response of Metastatic Brain Tumor to Gamma Knife Radiosurgery by Radiomics With a Machine Learning Method.

Authors:  Daisuke Kawahara; Xueyan Tang; Chung K Lee; Yasushi Nagata; Yoichi Watanabe
Journal:  Front Oncol       Date:  2021-01-11       Impact factor: 6.244

4.  Computer Tomography Radiomics-Based Nomogram in the Survival Prediction for Brain Metastases From Non-Small Cell Lung Cancer Underwent Whole Brain Radiotherapy.

Authors:  Ji Zhang; Juebin Jin; Yao Ai; Kecheng Zhu; Chengjian Xiao; Congying Xie; Xiance Jin
Journal:  Front Oncol       Date:  2021-02-11       Impact factor: 6.244

Review 5.  Classification of true progression after radiotherapy of brain metastasis on MRI using artificial intelligence: a systematic review and meta-analysis.

Authors:  Hae Young Kim; Se Jin Cho; Leonard Sunwoo; Sung Hyun Baik; Yun Jung Bae; Byung Se Choi; Cheolkyu Jung; Jae Hyoung Kim
Journal:  Neurooncol Adv       Date:  2021-07-01

6.  Quality of Radiomics Research on Brain Metastasis: A Roadmap to Promote Clinical Translation.

Authors:  Chae Jung Park; Yae Won Park; Sung Soo Ahn; Dain Kim; Eui Hyun Kim; Seok-Gu Kang; Jong Hee Chang; Se Hoon Kim; Seung-Koo Lee
Journal:  Korean J Radiol       Date:  2022-01       Impact factor: 3.500

7.  Radiographic markers of breast cancer brain metastases: relation to clinical characteristics and postoperative outcome.

Authors:  Anna Michel; Thiemo Dinger; Marvin Darkwah Oppong; Laurèl Rauschenbach; Cornelius Deuschl; Yahya Ahmadipour; Daniela Pierscianek; Karsten Wrede; Jörg Hense; Christoph Pöttgen; Antonella Iannaccone; Rainer Kimmig; Ulrich Sure; Ramazan Jabbarli
Journal:  Acta Neurochir (Wien)       Date:  2021-10-22       Impact factor: 2.216

Review 8.  Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential.

Authors:  Xingping Zhang; Yanchun Zhang; Guijuan Zhang; Xingting Qiu; Wenjun Tan; Xiaoxia Yin; Liefa Liao
Journal:  Front Oncol       Date:  2022-02-17       Impact factor: 6.244

Review 9.  Beyond Glioma: The Utility of Radiomic Analysis for Non-Glial Intracranial Tumors.

Authors:  Darius Kalasauskas; Michael Kosterhon; Naureen Keric; Oliver Korczynski; Andrea Kronfeld; Florian Ringel; Ahmed Othman; Marc A Brockmann
Journal:  Cancers (Basel)       Date:  2022-02-07       Impact factor: 6.639

10.  Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgery.

Authors:  Anna Michel; Thiemo Florin Dinger; Alejandro N Santos; Daniela Pierscianek; Marvin Darkwah Oppong; Yahya Ahmadipour; Philipp Dammann; Karsten H Wrede; Jörg Hense; Christoph Pöttgen; Antonella Iannaccone; Rainer Kimmig; Ulrich Sure; Ramazan Jabbarli
Journal:  J Neurooncol       Date:  2022-06-07       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.